Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Hantavax in Healthy Adults
NCT02553837Phase 3Unknown
- Sponsor
- GC Biopharma
- Start
- Nov 2015
- Primary completion
- Aug 2017
- Modality
- Whole Inactivated Vaccines
01
Overview
A Phase 3 trial of hantavax in hemorrhagic fever with renal syndrome (HFRS), sponsored by GC Biopharma. Status: unknown.
02
Drugs
hantavax
03
Conditions
hemorrhagic fever with renal syndrome (HFRS)
Beyond the preview
Go deeper on NCT02553837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02553837.